IP Library Assignment 046239/0975
Patent Assignment
Reel/Frame 046239/0975

Change of Name

Recorded: 2018-05-24 Pages: 9
Assignor
PROVECTUS PHARMACEUTICALS, INC.
Executed: 2013-12-17
Assignee
PROVECTUS BIOPHARMACEUTICALS, INC.
10025 INVESTMENT DR STE 250, KNOXVILLE, TENNESSEE, 37932-2664
Covered Properties (11)
Method for Improved Imaging and Photodynamic Therapy
Patent: 6,493,570 →
Application: 09/184,388 →
Improved Methods for High Energy Phototherapeutics
Patent: 6,331,286 →
Application: 09/216,787 →
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,495,360 →
Application: 09/543,479 →
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,451,597 →
Application: 09/803,498 →
Publication: US 2001/0041354
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,541,223 →
Application: 09/803,609 →
Publication: US 2001/0044146
Method for Enhanced Protein Stabilization and for Production of Cell Lines Useful for Production of Such Stabilized Proteins
Patent: 6,468,777 →
Application: 09/803,634 →
Publication: US 2001/0041361
Ultrasound Contrast Using Halogenated Xanthenes
Patent: 6,986,740 →
Application: 10/314,840 →
Publication: US 2003/0167006
Intracorporeal Medicaments for High Energy Phototherapeutic Treatment of Disease
Patent: 6,991,776 →
Application: 10/331,854 →
Publication: US 2003/0125376
Combination Antiperspirant and Antimicrobial Composition
Patent: 7,201,914 →
Application: 10/425,255 →
Publication: US 2003/0215408
Combination of Rose Bengal and Systemic Immunomodulative Therapies for Enhanced Treatment of Cancer
Patent: 9,839,688 →
Application: 14/748,608 →
Publication: US 2015/0290165
Combination of Local and Systemic Immunomodulative Therapies for Melanoma and Liver Cancer
Patent: 9,808,524 →
Application: 14/748,634 →
Publication: US 2015/0290318
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Jun 13, 2005
From: PROVECTUS PHARMATECH, INC.
To: DCOFI MASTER LDC, AS AGENT
Reel/Frame 016127/0687 →
Security Agreement Jun 13, 2005
From: PURE-IFIC CORPORATION
To: DCOFI MASTER LDC, AS AGENT
Reel/Frame 016132/0118 →
Security Agreement Jun 13, 2005
From: PROVECTUS PHARMACEUTICALS, INC.
To: DCOFI MASTER LDC, AS AGENT
Reel/Frame 016127/0746 →
Security Agreement Jun 13, 2005
From: PROVECTUS BIOTECH, INC.
To: DCOFI MASTER LDS, AS AGENT
Reel/Frame 016127/0714 →
Assignment of Assignor's Interest Mar 22, 2007
From: XANTECH PHARMACEUTICALS, INC.
To: PUREIFIC CORP.
Reel/Frame 019049/0105 →
Release of Security Interest Apr 26, 2007
From: DCOFI MASTER LDC
To: PURE-IFIC CORPORATION
Reel/Frame 019217/0568 →
Release of Security Interest Apr 27, 2007
From: DCOFI MASTER LDC
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 019215/0778 →
Release of Security Interest Apr 27, 2007
From: DCOFI MASTER LDC
To: PROVECTUS PHARMACEUTICALS, INC.
Reel/Frame 019215/0669 →
Release of Security Interest Apr 27, 2007
From: DCOFI MASTER LDC
To: PROVECTUS BIOTECH, INC.
Reel/Frame 019215/0635 →
Corrective Assignment to Correct the Assignee Name Previously Recorded on Reel 019049 Frame 0105. Assignor(S) Hereby Confirms the to Correct the Spelling of the Assignee Name from "Pureific Corp.;" to Pure-Ific Corp.. Jan 9, 2008
From: XANTECH PHARMACEUTICALS, INC.
To: PURE-IFIC CORP.
Reel/Frame 020339/0249 →
Assignment of Assignor's Interest Feb 3, 2016
From: PROVECTUS PHARMACEUTICALS, INC
To: PROVECTUS PHARMATECH, INC.
Reel/Frame 037651/0781 →
Security Interest Apr 4, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0389 →
Security Interest Apr 4, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0498 →
Security Interest Apr 4, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: WACHTER, ERIC A.; CAL ENTERPRISES LLC
Reel/Frame 042188/0443 →
Security Interest Apr 21, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0421 →
Security Interest Apr 21, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0516 →
Security Interest Apr 21, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: MORRIS, JEFFREY A.
Reel/Frame 042091/0594 →
Security Interest Jun 26, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SCOTT A.; TAUSK, SANDRA J.
Reel/Frame 042809/0755 →
Security Interest Jun 26, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SANDRA J.; TAUSK, SCOTT A.
Reel/Frame 042809/0817 →
Security Interest Jun 26, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TAUSK, SCOTT A.; TAUSK, SANDRA J.
Reel/Frame 042809/0878 →
Security Interest Aug 1, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043156/0410 →
Security Interest Aug 1, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043157/0330 →
Security Interest Aug 1, 2017
From: PURE-IFIC CORP.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: PATRICIA F. BISCHOFF REVOCABLE TRUST
Reel/Frame 043157/0439 →
Security Interest Aug 9, 2017
From: PROVECTUS PHARMATECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043244/0210 →
Security Interest Aug 9, 2017
From: PROVECTUS BIOTECH, INC.; PROVECTUS BIOPHARMACEUTICALS, INC.
To: TED R. WATSON REVOCABLE TRUST
Reel/Frame 043244/0424 →